Mounjaro 12.5mg KwikPen

About Mounjaro 12.5mg KwikPen

Mounjaro 12.5mg KwikPen is a once-weekly injectable medication containing tirzepatide, indicated for the management of type 2 diabetes mellitus in adults. It helps improve glycemic control by activating both GIP and GLP-1 receptors, supporting better blood sugar regulation and aiding in weight management when combined with proper diet and exercise.

The KwikPen device is designed for convenient, easy-to-use subcutaneous administration, ensuring accurate dosing and patient comfort.

• Once-weekly dosing for improved compliance

• Helps reduce HbA1c levels effectively

• Supports weight reduction in adults with type 2 diabetes

• Pre-filled, ready-to-use KwikPen for simple administration

• Reliable quality from a globally trusted pharmaceutical company

• Type 2 Diabetes Mellitus (as monotherapy or in combination with other antidiabetic medications)

• To be used alongside a healthy diet and regular exercise

• Administered once weekly via subcutaneous injection (abdomen, thigh, or upper arm)

• Dose escalation should be done under medical supervision

• Use strictly as prescribed by a registered medical practitioner

• Store refrigerated at 2C to 8C

• Do not freeze

• Protect from direct sunlight

• Keep out of reach of children

• Prescription-only medication

• Not recommended for patients with type 1 diabetes

• Consult a doctor before use if pregnant, breastfeeding, or suffering from pancreatitis or severe gastrointestinal disease